Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Tandy J. Miller"'
1
Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
Autor: Scott W. Woods, John H. Krystal, Keith A. Hawkins, Deepak Cyril D'Souza, Godfrey D. Pearlson, John R. Saksa, Tandy J. Miller, Daniel C. Javitt, Thomas H. McGlashan, Barbara Walsh
Publikováno v: European Neuropsychopharmacology. 23:931-940
Patients meeting criteria for the risk syndrome for psychosis have treatment needs including positive and negative symptoms and cognitive impairment. These features could potentially respond to NMDA glycine-site agonists. The present objective was to
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a52c594abf9822d0c7508e7cf8be81
https://doi.org/10.1016/j.euroneuro.2012.09.008
Zobrazit plný text záznamu
2
Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome
Autor: Scott W. Woods, Tandy J. Miller, Thomas H. McGlashan, Joanna Lifshey Rosen, Jennifer T. D'Andrea
Publikováno v: Schizophrenia Research. 85:124-131
While schizophrenia is often associated with a variety of concurrent psychiatric symptoms, little attention has been paid to the prevalence of psychiatric comorbidity in prodromal patients. The current study examines the presence of comorbid current
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db8a93b893cbf2689c818d5aebb8fa5e
https://doi.org/10.1016/j.schres.2006.03.034
Zobrazit plný text záznamu
3
Factorial structure of the Scale of Prodromal Symptoms
Autor: Tom McGlashan, Tandy J. Miller, Keith A. Hawkins, Scott W. Woods, Jean Addington, Diana O. Perkins, Donald M. Quinlan, Robert B. Zipursky
Publikováno v: Schizophrenia Research. 68:339-347
Data from the Scale of Prodromal Symptoms (SOPS) [Early Intervention in Psychotic Disorders, pp. 135–150] on 94 hitherto never-psychotic individuals were entered into a principal components analysis, revealing six components with an eigenvalue grea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925fffe346a45064f0fe8495698becae
https://doi.org/10.1016/s0920-9964(03)00053-7
Zobrazit plný text záznamu
4
Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
Autor: Tandy J. Miller, Thomas H. McGlashan, Mauricio Tohen, E. Marquez, Keith A. Hawkins, Jean Addington, Diana O. Perkins, Alan Breier, Scott W. Woods, Robert B. Zipursky, Stacy R. Lindborg
Publikováno v: Biological Psychiatry. 54:453-464
The prodromal phase of schizophrenic disorders has been described prospectively. The present study aimed to determine the short-term efficacy and safety of olanzapine treatment of prodromal symptoms compared with placebo.This was a double-blind, rand
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cd66033f0f44f24f8d0e256d079473b
https://doi.org/10.1016/s0006-3223(03)00321-4
Zobrazit plný text záznamu
5
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
Autor: Jean Addington, Mauricio Tohen, Diana O. Perkins, Stacy R. Lindborg, Scott W. Woods, Robert B. Zipursky, Keith A. Hawkins, Alan Breier, Tandy J. Miller, Thomas H. McGlashan, Ralph E. Hoffman
Publikováno v: Schizophrenia Research. 61:7-18
The first double-blind placebo-controlled clinical trial of an atypical neuroleptic medication is being conducted in symptomatic treatment-seeking patients meeting new diagnostic criteria for a putative prodromal syndrome. This identifies them as bei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a87d1c7810e458250e061529d51325fc
https://doi.org/10.1016/s0920-9964(02)00439-5
Zobrazit plný text záznamu
6
The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis
Autor: Mauricio Tohen, Robert B. Zipursky, D. Addington, Irvin Epstein, Jean Addington, Keith A. Hawkins, Diana O. Perkins, Tandy J. Miller, Adrian Preda, Alan Breier, E. Marquez, Ralph E. Hoffman, Stacy R. Lindborg, Thomas H. McGlashan, Scott W. Woods
Publikováno v: Schizophrenia Research. 61:19-30
The first double-blind placebo-controlled clinical trial of an atypical neuroleptic medication is being conducted in symptomatic treatment-seeking patients meeting new diagnostic criteria for a putative prodromal syndrome. This identifies them as bei
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::872938b89638d5a2421bacade0c99e6b
https://doi.org/10.1016/s0920-9964(02)00440-1
Zobrazit plný text záznamu
8
Prodromal Assessment With the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: Predictive Validity, Interrater Reliability, and Training to Reliability
Autor: William R. McFarlane, Kristen Cadenhead, Scott W. Woods, Diana O. Perkins, Joanna Lifshey Rosen, Tandy J. Miller, Joseph Ventura, Thomas H. McGlashan, Godfrey D. Pearlson
Publikováno v: Schizophrenia Bulletin. 29:703-715
As the number of studies related to the early identification of and intervention in the schizophrenia prodrome continues to grow, it becomes increasingly critical to develop methods to diagnose this new clinical entity with validity. Furthermore, giv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b3966eb38af4b341d0284899a710d902
https://doi.org/10.1093/oxfordjournals.schbul.a007040
Zobrazit plný text záznamu
9
PROSPECTIVE OBSERVATIONS OF EMERGING PSYCHOSIS
Autor: Joanna Lifshey Rosen, Scott W. Woods, Tandy J. Miller, Thomas H. McGlashan
Publikováno v: The Journal of Nervous and Mental Disease. 190:133-141
Because delays in treatment of psychosis may be associated with poorer outcomes, intervention focus has shifted to the prodromal phase of illness. However, knowledge about this phase has been limited to retrospective reconstructions of symptoms once
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d7c11a35ccd944017ec901df0de325
https://doi.org/10.1097/00005053-200203000-00001
Zobrazit plný text záznamu
10
Estimated yield of early detection of prodromal or first episode patients by screening first degree relatives of schizophrenic patients
Autor: Larry Davidson, Keith A. Hawkins, Tandy J. Miller, Michael J. Sernyak, Scott W. Woods, Thomas H. McGlashan
Publikováno v: Schizophrenia Research. 52:21-27
Screening a population of relatives of current schizophrenic patients could be an efficient means to accrue a sample of early first episode or prodromal patients for a prediction study or an intervention study. The risk of new onset schizophrenia cas
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74445401a2f1088c5178dc5004e47ebc
https://doi.org/10.1016/s0920-9964(01)00158-x
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje